COMMUNIQUÉS West-GlobeNewswire

Acura Pharmaceuticals Announces Fourth Quarter 2018 and Full Year 2018 Financial Results
16/09/2019
PALATINE, Ill., Sept. 16, 2019 (GLOBE NEWSWIRE) -- Acura Pharmaceuticals, Inc., a specialty pharmaceutical company engaged in the research, development and commercialization of technologies and product candidates [...]
10x Genomics Announces Closing of Initial Public Offering and Exercise in Full of the Underwriters’ Option to Purchase Additional Shares
16/09/2019
PLEASANTON, Calif., Sept. 16, 2019 (GLOBE NEWSWIRE) -- 10x Genomics (Nasdaq: TXG) today announced the closing of its initial public offering of 11,500,000 shares of its Class A common stock, which includes the exercise [...]
Cidara Therapeutics to Participate in Two Upcoming Investor Conferences
16/09/2019
SAN DIEGO, Sept. 16, 2019 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company developing novel anti-infectives including immunotherapies, today announced that Paul Daruwala, chief [...]
Evolve Treatment Centers Joins Silicon Valley Pride Parade
16/09/2019
Evolve San Jose participated in the 2019 LGBTQ parade to spread awareness about mental health resources for struggling adolescents SAN JOSE, Calif., Sept. 16, 2019 (GLOBE NEWSWIRE) -- To demonstrate support for LGBTQ+ [...]
Nextech to Showcase Top Ranked Solutions at Plastic Surgery The Meeting 2019
16/09/2019
Nextech offers a variety of innovative tools and consulting services to help plastic surgery practices optimize practice efficiency and profitability at ASPS TAMPA, Fla., Sept. 16, 2019 (GLOBE NEWSWIRE) -- Nextech [...]
Generex Announces That the Process to Retire 20,375,900 GNBT “Pool Shares” is Complete
16/09/2019
Retirement of Pool shares will be Reflected in 31.9% reduction in Outstanding Shares MIRAMAR, Fla., Sept. 16, 2019 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation ( www.generex.com ) (OTCQB:GNBT) ( http://www. [...]
Intrommune Therapeutics Supports Outcome of FDA Allergenic Product Advisory Committee Vote
16/09/2019
APAC Vote Confirms Benefit of Oral Immunotherapy for Peanut Allergy; Paves Way for Relief for Thousands of Peanut Allergy Sufferers New York, Sept. 16, 2019 (GLOBE NEWSWIRE) -- Intrommune Therapeutics , a New York-based [...]
Transactions under Novozymes’ stock buyback program
16/09/2019
Please read the full announcement in the attached PDF Attachment 2019_36_Stock_Buybackprogram_EN
Correction: Summary of capital reduction pursuant to Article 32 of the Danish Capital Markets Act
16/09/2019
Please read the full announcement here Attachment 2019_35_Correction_Summary_of_capital_reduction_EN
CellaVision invites to a telephone and audio webcast on September 17, at 11:00 CET to present the signing of an agreement to acquire the French company RAL Diagnostics
16/09/2019
The information was submitted to the public on September 16, 2019 at 18:45 CET CellaVision AB (publ) announced on September 16, 2019, at 18:30 CET that the company has signed an agreement to acquire the French company [...]
CellaVision AB to acquire RAL Diagnostics
16/09/2019
A unique combination of high-quality sample preparation and world-leading digital cell morphology. The information was released for public disclosure on September 16, 2019, at 18:30 CET CellaVision AB is today [...]
Pluristem Therapeutics Recaps Key Opinion Leader Call Reviewing Hematological Programs
16/09/2019
PLX-R18 is currently in development as a countermeasure for acute radiation syndrome and as a treatment for incomplete recovery following hematopoietic cell transplantation Data from 1 st and 2 nd cohorts of [...]
PHASTAR Looks to Expand its Global Footprint with U.S. West Coast Office
16/09/2019
DURHAM, N.C. and LONDON, Sept. 16, 2019 (GLOBE NEWSWIRE) -- PHASTAR , a global CRO, is pursuing an aggressive growth strategy that will include the establishment of a U.S. west coast office in California. The company [...]
Sanofi: information concerning the total number of voting rights and shares, August 2019
16/09/2019
Information concerning the total number of voting rights and shares, provided pursuant to article L. 233-8 II of the Code de commerce (the French Commercial Code) and article 223-16 of the Règlement général de l’ [...]
Sanofi : informations relatives au nombre total de droits de vote et d’actions, août 2019
16/09/2019
Informations relatives au nombre total de droits de vote et d’actions prévues par l’article L. 233-8 II du Code de commerce et l’article 223-16 du Règlement général de l’Autorité des Marchés Financiers Sanofi Société [...]
Virbac: operating profit on the rise in the first half of 2019
16/09/2019
Operating profit on the rise in the first half of 2019 CONSOLIDATED DATA AS OF JUNE 30 in € million 2019 2018 % change 2019/2018 Revenue from ordinary activities 463.7 430.0 +7.9% Evolution at constant exchange rates +6 [...]
Virbac : résultat opérationnel courant du premier semestre 2019 en forte croissance
16/09/2019
Résultat opérationnel courant du premier semestre 2019 en forte croissance CHIFFRES CONSOLIDÉS AU 30 JUIN en millions € 2019 2018 Évolution 2019/2018 Chiffre d’affaires 463,7 430,0 +7,9% Évolution à taux de change [...]
Virbac : Rapport financier semestriel 2019
16/09/2019
Ci-joint le rapport financier semestriel 2019 de Virbac Pièce jointe Rapport financier semestriel_Juin 2019
Virbac : Half-yearly financial report 2019
16/09/2019
Please find attached 2019 Half-yearly financial report of Virbac Attachment Half-yearly financial report_June 2019

Pages